CAS: 1355446-05-7
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | ML309 REF: TM-T70890CAS: 1355446-05-7 | - - - | 1.444,00 €~2.375,00 € | Qui 15 Mai 25 |
 | 2-(2-(1H-Benzo[D]imidazol-1-yl)-N-(3-fluorophenyl)acetamido)-N-cyclopentyl-2-(o-tolyl)acetamide REF: 3D-FEC44605CAS: 1355446-05-7 | Min. 95% | - - - | Produto descontinuado |
ML309
CAS:1355446-05-7
ML309 inhibits R132H mutant IDH1, reduces 2-HG in U87 MG glioblastoma.
Fórmula:
C29H29FN4O2
Cor e Forma:
Liquid
Peso molecular:
484.56
Ref: TM-T70890
| 25mg | 1.444,00 € | ||
| 50mg | 1.882,00 € | ||
| 100mg | 2.375,00 € |
Entrega estimada em Estados Unidos, Quinta-feira 15 de Maio de 2025
![2-(2-(1H-Benzo[D]imidazol-1-yl)-N-(3-fluorophenyl)acetamido)-N-cyclopentyl-2-(o-tolyl)acetamide](https://static.cymitquimica.com/products/3D/thumb/FEC44605.jpg)
2-(2-(1H-Benzo[D]imidazol-1-yl)-N-(3-fluorophenyl)acetamido)-N-cyclopentyl-2-(o-tolyl)acetamide
CAS:1355446-05-7
(2-(2-(1H-benzo[d]imidazol-1-yl)-N-(3-fluorophenyl)acetamido)-N-cyclopentyl-2-(o-tolyl)acetamide) is a ligand that binds to the benzodiazepine site of the GABA receptor. It …
Fórmula:
C29H29FN4O2
Pureza:
Min. 95%
Peso molecular:
484.6 g/mol
Ref: 3D-FEC44605
| 100mg | Descontinuado | Solicitar informações |
